Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Most Cited Paper
in Tuberculosis Research and Epidemiology
18 Months Post-Publication
Class of 2026
“Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
psoriasis · Latent tuberculosis infection · IL-17 inhibitors · IL-23 inhibitors · Tuberculosis reactivation · TNF inhibitors · chemoprophylaxis · tuberculin skin test · IGRA · ixekizumab · hepatotoxicity · chronic plaque psoriasis · Active tuberculosis · Tuberculosis screening · biologic therapy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Tuberculosis Research and Epidemiology Papers, Class of 2026. https://pri.pepkio.com/top-papers/tuberculosis-research-and-epidemiology/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459